West Pharmaceutical Services Inc.
Net Cash Flow Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
FY2008
Total Cash from Operations: $280.2M
| Line Item | Value | % of Total |
|---|---|---|
| Capital Expenditures | $130.8M | 46.7% |
| Other Investing | $2.8M | 1.0% |
| Dividends Paid | $39.1M | 14.0% |
| Stock Repurchases | $74.4M | 26.6% |
| Working Capital | $200.0K | 0.1% |
| Net Cash Flow | $32.9M | 11.7% |